Talecris Biotherapeutics Inc.; est. no. 1716

Talecris Biotherapeutics Inc. - Research Triangle Park, NC; In April 2005, Talecris, a subsidiary of NPS BioTherapeutics Inc., acquired Bayer’s plasma products business for $590 million, but this did not include Bayer’s recombinant hemophilia products; Talecris also acquired the plasma fractionation and contract manufacturing facilities of Precision Pharma Services Inc.; Bayer continued to distribute plasma products for Talecris outside the U.S.; Talecris was formed with funding from Cerberus Capital Management and Ampersand Ventures; In June. 2010, Grifols acquired Talecris for $3.4 billion.

Related product monographs:

1. Antithrombin III/Talecris -- Manuf. ; R&D ; Tech. ; USA mark. ; Parent
2. Antitrypsin, alpha-1/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
3. Aprotinin -- Manuf. ; R&D ; Tech. ; USA mark.
4. Factor VIII/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
5. Factor VIII:vWF/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
6. Factor IX Complex/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
7. Fibrin sealant/OMRIX -- Manuf. other
8. Hepatitis B Immune Globulin/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
9. Immune Globulin (IGIM)/Talecris -- Manuf. ; Tech. ; USA mark.
10. Immune Globulin (IGIV-C) -- Manuf. ; R&D ; Tech. ; USA mark.
11. Immune Globulin (IGIV)/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
12. Rabies Immune Globulin/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
13. Rho(D) Immune Globulin/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
14. Tetanus Immune Globulin/Talecris -- Manuf. ; R&D ; Tech. ; USA mark.
15. Plasma SD/Grifols -- Manuf. ; R&D ; Tech.
16. Plasma Protein Fraction -- Manuf. ; USA mark.

Location - Research Triangle Park NC USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute